| Serial Number | 86983196 |
| Word Mark | ALLERGAN |
| Filing Date | Friday, June 12, 2015 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 10, 2018 |
| Registration Number | 5443889 |
| Registration Date | Tuesday, April 10, 2018 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 1, 2016 |
| Description of Mark | The mark consists of the word "ALLERGAN" in a stylized dark blue font to the left of which is a stylized futuristic comet design comprised of circles that are as follows moving from right to left: three large dark blue circles, followed next by four medium blue circles that are large on the outside with the two middle circles being smaller, followed next by three small light blue circles, followed next by three large green circles, followed next by three smaller medium green circles, followed next by three small yellow circles, with the last circle being the point of the comet. |
| Goods and Services | House mark used for a line of pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations, and pharmaceutical preparations to treat and prevent glaucoma; ocular wetting solutions, namely, eye drops, artificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, central nervous system disorders, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; medicated cosmetic skin care preparations |
| Indication of Colors claimed | The color(s) dark blue, medium blue, light blue, green, medium green, and yellow is/are claimed as a feature of the mark. |
| Goods and Services | House mark used for a line of surgical, medical, dental and veterinary apparatus and instruments, namely, diagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; medical devices for treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for use in facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics and ophthalmic related diseases and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 17, 2015 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, June 30, 2017 |
| First Use In Commerce Date | Friday, June 30, 2017 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 17, 2015 |
| Primary Code | 010 |
| First Use Anywhere Date | Wednesday, October 12, 2016 |
| First Use In Commerce Date | Wednesday, October 12, 2016 |
| Party Name | Allergan, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | North Chicago, IL 60064 |
| Party Name | Allergan, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92612 |
| Party Name | Allergan, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92612 |
| Event Date | Event Description |
| Monday, February 5, 2024 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, April 10, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, April 10, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, April 10, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 10, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, April 10, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, April 10, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, April 10, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, March 3, 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, March 2, 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, February 9, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 9, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 8, 2018 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, October 27, 2017 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, October 27, 2017 | FINAL REFUSAL E-MAILED |
| Friday, October 27, 2017 | SU - FINAL REFUSAL - WRITTEN |
| Wednesday, October 25, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 25, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 24, 2017 | ASSIGNED TO LIE |
| Tuesday, October 10, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 4, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, October 4, 2017 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 4, 2017 | SU - NON-FINAL ACTION - WRITTEN |
| Friday, September 29, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, September 28, 2017 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, September 20, 2017 | USE AMENDMENT FILED |
| Thursday, September 28, 2017 | DIVISIONAL PROCESSING COMPLETE |
| Wednesday, September 20, 2017 | DIVISIONAL REQUEST RECEIVED |
| Thursday, September 28, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, September 20, 2017 | TEAS REQUEST TO DIVIDE RECEIVED |
| Wednesday, September 20, 2017 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, March 28, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, March 24, 2017 | SOU EXTENSION 2 GRANTED |
| Friday, March 24, 2017 | SOU EXTENSION 2 FILED |
| Friday, March 24, 2017 | SOU TEAS EXTENSION RECEIVED |
| Friday, September 16, 2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 14, 2016 | SOU EXTENSION 1 GRANTED |
| Wednesday, September 14, 2016 | SOU EXTENSION 1 FILED |
| Wednesday, September 14, 2016 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 26, 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 1, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 1, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 10, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 22, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 22, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Friday, January 22, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, January 22, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Friday, January 22, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, January 20, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 19, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 19, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 22, 2015 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Tuesday, September 22, 2015 | PRIORITY ACTION E-MAILED |
| Tuesday, September 22, 2015 | PRIORITY ACTION WRITTEN |
| Tuesday, September 22, 2015 | ASSIGNED TO EXAMINER |
| Thursday, June 18, 2015 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, June 17, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 16, 2015 | NEW APPLICATION ENTERED |